17 October 2025
Finseta plc
("Finseta", "the Company" or "the Group")
Grant of Options, PDMR Dealing
Finseta (AIM: FIN), a foreign exchange and payments solutions company offering multi-currency accounts to businesses and individuals through its proprietary technology platform, announces that on 16 October 2025 (the "Grant Date") the Company granted a total of 150,000 options (the "Options") over ordinary shares of 1 penny each in the Company ("Ordinary Shares") to certain employees, including to a PDMR of the Company as follows:
| Name | Role | Number of Options Granted |
| Declan Jones | Chief Product Officer | 100,000 |
The Options vest in three equal tranches on the first, second and third anniversaries of the Grant Date and are exercisable at a price of 13.75 pence per Ordinary Share, representing the closing price of the Company's Ordinary Shares on AIM on 15 October 2025, being the day prior to the Grant Date. The vesting of the Options is subject to the individual remaining an employee of the Company. Leavers may exercise vested Options within 90 days of cessation of employment. All Options expire five years after the Grant Date.
Enquiries
| Finseta plc | +44 (0)203 971 4865 |
| James Hickman, Chief Executive Officer Judy Happe, Chief Financial Officer | |
| | |
| Shore Capital (Nominated Adviser and Broker) | +44 (0)207 408 4090 |
| Daniel Bush, Tom Knibbs (Corporate Advisory) Guy Wiehahn (Corporate Broking) | |
| | |
| Gracechurch Group (Financial PR) | +44 (0)204 582 3500 |
| Harry Chathli, Claire Norbury | |
About Finseta plc
Finseta plc (AIM: FIN) is a foreign exchange and payments company offering multi-currency accounts and payment solutions to businesses and individuals. Headquartered in the City of London, Finseta combines a proprietary technology platform with a high level of personalised service to support clients with payments in over 165 countries in 150 currencies. With a track record of over 15 years, Finseta has the expertise, experience and expanding global partner network to be able to execute complex cross-border payments. It is fully regulated, through its wholly-owned subsidiaries, by the Financial Conduct Authority as an Electronic Money Institution; by the Financial Transactions and Reports Analysis Centre of Canada as a Money Services Business; and by the Dubai Financial Services Authority under a Category 3D licence. www.finseta.com
The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, provide further detail.
| 1
| Details of the person discharging managerial responsibilities/person closely associated
| |||||
| a)
| Name
| Declan Jones | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Chief Product Officer | ||||
| b)
| Initial notification/amendment
| Initial Notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Finseta plc | ||||
| b)
| LEI
| 213800O4IL2RXZ2BZ956 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument | Options over ordinary shares of 1 penny each | ||||
| | | |||||
| Identification code | GB00BNG7CD28 | |||||
| | | |||||
| b)
| Nature of the transaction
| Grant of options | ||||
| c)
| Price(s) and volume(s) | | | | | |
| | | Price(s) | Volume(s) | | ||
| | | 13.75 pence | 100,000 |
| ||
| | | | | | ||
| d)
| Aggregated information | N/A | ||||
| | | |||||
| - Aggregated volume | | |||||
| | | |||||
| - Price | | |||||
| | | |||||
| e)
| Date of the transaction
| 16 October 2025 | ||||
| f)
| Place of the transaction
| Off market | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.